Innovaccer Launches ‘Innovaccer Gravity™': The Healthcare Intelligence Platform to Accelerate AI-Driven Transformation
SAN FRANCISCO, May 22, 2025--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, today announced the launch of 'Innovaccer Gravity™', its Healthcare Intelligence Platform, designed to help organizations unlock the full value of their data and accelerate AI-driven transformation. Innovaccer Gravity™ seamlessly integrates healthcare enterprise data, enables cross-domain intelligence, and delivers faster return on investment (ROI), all while reducing total cost of ownership (TCO).
Built on a modern, cloud-agnostic architecture with enterprise-grade security and compliance (HIPAA, HITRUST), Innovaccer Gravity™ unifies data from electronic health records (EHRs), claims, financial, operational, supply chain, HR and other core systems into a single source of truth. The platform's healthcare-native design, with 400+ pre-built connectors and 100+ FHIR resources, enables interoperability across clinical, operational, and financial domains, empowering leaders to drive better patient care, streamline operations, and improve financial performance.
"Health systems are under unprecedented pressure to do more with less, from improving outcomes to optimizing operations, all while managing rising costs," said Abhinav Shashank, cofounder and CEO of Innovaccer. "Gravity is purpose-built to address these challenges. It unifies data, scales AI adoption, and activates real-time insights, enabling healthcare organizations to drive meaningful change, faster and more cost-effectively."
Key capabilities of Innovaccer Gravity™ include:
Unified Data Fabric: Integrates clinical, operational, and financial data into a single, trusted foundation with real-time alerts and actionable insights.
AI-First Enterprise Intelligence Layer: Leverages Innovaccer's AI framework to provide pre-built foundational AI models (text-to-speech, speech-to-text, OCR, speech analytics) built for healthcare and customizable AI/ML workbenches.
Low-Code/No-Code Self-Serve Tools: Empowers analysts, scientists, and developers to rapidly build and deploy agents, solutions using open APIs and self-service AI/ML capabilities.
Build and Extend with Your Own Data and AI: Enables organizations to bring their own data, build custom analytics, develop AI models, and create tailored applications on top of Innovaccer's rich content library and pre-built assets.
Enterprise-Grade Security & Governance: Ensures data integrity with built-in master data management, data governance, and cloud-agnostic scalability.
Accelerated Time-to-Value: Reduces deployment timelines from months to weeks, driving faster adoption of business-critical use cases.
Innovaccer Gravity™ is designed for health system leaders, including CFOs, CIOs, CTOs, and CDOs, who are seeking to modernize legacy infrastructure, improve operational efficiency, and demonstrate tangible ROI on data initiatives.
With its future-proof architecture and healthcare-native intelligence, Gravity positions Innovaccer as the definitive platform for health systems seeking to accelerate digital transformation.
Innovaccer Gravity™ beta is now available to health systems across the U.S, with general access in upcoming quarters.
For more information about Innovaccer Gravity™, the Healthcare Intelligence Platform, visit get-gravity.ai.
About Innovaccer
Innovaccer activates the flow of healthcare data, empowering providers, payers, and government organizations to deliver intelligent and connected experiences that advance health outcomes. The Healthcare Intelligence Cloud equips every stakeholder in the patient journey to turn fragmented data into proactive, coordinated actions that elevate the quality of care and drive operational performance. Leading healthcare organizations like CommonSpirit Health, Atlantic Health, and Banner Health trust Innovaccer to integrate a system of intelligence into their existing infrastructure— extending the human touch in healthcare. For more information, visit www.innovaccer.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250522560091/en/
Contacts
Press Contact:Arushi AwasthiInnovaccer Inc.arushi.awasthi@innovaccer.com 415-562-2139
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
a minute ago
- Associated Press
Cavitation Technologies, Inc. Signs an Agreement with BMI Group to Advance 'Forever Chemicals' Removal Using Chemical Free Proprietary Technology
CHATSWORTH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Cavitation Technologies, Inc. ('CTi' or the 'Company') (OTCQB: CVAT), a pioneer in advanced fluid processing and water treatment, today announced that it has entered into an agreement with BMI Group, a Canadian environmental solutions provider specializing in large-scale water and wastewater treatment projects. Clean water has never been more critical, and never more at risk. Industry has disposed of at least 60 million pounds of 'forever chemicals' (PFAS) in the U.S. over the past five years. These are among the most dangerous chemicals and they can't be seen, smelled, or tasted, yet they're everywhere: in our water, soil, and air. The problem isn't finding PFAS, it's removing them. Under the agreement, BMI Group will hold certain exclusivity rights within its territory and is required to achieve a minimum of $1 million in annual sales. This collaboration aims to deliver a more effective and scalable process for removing 'forever chemicals' (PFAS) that pose significant environmental and health risks. The agreement includes rental fees for the units and the initial shipment of both the High-Pressure Nano-Reactor® and Cavitation Non-Thermal Plasma™ systems, which have already been delivered. 'PFAS contamination is one of the most persistent and costly environmental challenges of our time,' said Neil Voloshin, CEO of Cavitation Technologies, Inc. 'By combining our patented High-Pressure Nano-Reactor® with Cavitation Non-Thermal Plasma™, we've developed an innovative solution that's both scalable and effective.' Current PFAS removal methods fall short: High-Pressure Nano-Reactor® + Cavitation Non-Thermal Plasma™ Advantage: The technology is also designed to: A Multi-Industry Impact Beyond PFAS removal, CTi's High-Pressure Nano-Reactor® and Cavitation Non-Thermal Plasma™ are driving change across multiple sectors, including industrial water and wastewater treatment, Bitcoin mining, agriculture, pharmaceuticals, high-precision electronics, and desalination. Together, these technologies deliver chemical-free, scalable treatment that removes a wide range of contaminants, improves water quality, and reduces operational costs for industries worldwide. About BMI Group Founded in 2005, BMI Group is a Canadian-based engineering and environmental solutions company specializing in the design, construction, and operation of water and wastewater treatment facilities. With a track record of delivering high-performance, sustainable infrastructure, BMI Group serves municipalities, industrial clients, and government agencies across North America. About Cavitation Technologies, Inc. Founded in 2007, Cavitation Technologies, Inc. (OTCQB: CVAT), is a leading ESG company that designs and manufactures innovative flow-through nano-technology systems for fluid processing applications worldwide. The technology is designed for fluid processing across multiple industries: water treatment and remediation, agriculture, pharmaceuticals, oil & gas, edible oil refining, renewable fuels, alcoholic and non-alcoholic beverage enhancement, PFAS removal, and now, high-performance computing and digital asset infrastructure. Our core products are Nano Reactor® systems, with scalable capacities ranging from 10 to 500 gallons per minute (GPM), and our latest advancement, Cavitation Non-Thermal Plasma™ technology, which currently operates at 25 GPM and is scalable to a larger flow. These systems effectively eliminate bacteria and viruses, reduce TDS levels, lower turbidity, and offer the removal of PFAS in multiple water remediation applications. CTi holds over 40 patents issued domestically and internationally. Follow our social media for real-time updates: Visit our websites for more information: Call or email us: Cavitation Technologies Inc. 818-718-0905 [email protected] Forward-Looking Statement This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as ''may,'' ''should,'' ''potential,'' ''continue,'' ''expects,'' ''anticipates,'' ''intends,'' ''plans,'' ''believes,'' ''estimates,'' and similar expressions. These forward-looking statements are based largely on the Company's expectations and are subject to many risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a variety of factors including, among others, our ability to install as anticipated, the state of the economy, the competitive environment and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties, there can be no assurances that the forward-looking statements contained in this press release will transpire or prove to be accurate. The information in this release is provided only as of the release date, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law. A photo accompanying this announcement is available at
Associated Press
a minute ago
- Associated Press
Excelerate Energy Reports Strong Second Quarter 2025 Results and Raises Full-Year Guidance
THE WOODLANDS, Texas--(BUSINESS WIRE)--Aug 11, 2025-- Excelerate Energy, Inc. (NYSE: EE) ('Excelerate' or the 'Company') today reported its financial results for the second quarter ended June 30, 2025. RECENT HIGHLIGHTS CEO COMMENT 'Excelerate delivered another robust quarter, demonstrating the strength of our business model and our focus on operational excellence. Our results reflect the performance of our terminal services and early contributions from our Jamaica operations,' said Steven Kobos, President and CEO of Excelerate. 'The Jamaica transaction represents a strategic inflection point for Excelerate. Our growth strategy has long included owning and operating downstream infrastructure assets and today, our business model reflects that ambition. With the addition of the Montego Bay and Old Harbour LNG terminals and the Clarendon CHP plant, we've expanded our role in the LNG value chain and created a more diversified platform for growth. We remain focused on executing against the opportunity set in front of us and creating lasting value for our shareholders.' SECOND QUARTER 2025 FINANCIAL RESULTS Net income for the second quarter of 2025 decreased sequentially from the last quarter due to transition and transaction costs incurred as a result of the Jamaica acquisition. Net income and adjusted net income also decreased sequentially due to higher interest expense, expected seasonality primarily related to Atlantic Basin margin, and timing of vessel operating costs, partially offset by the addition of Jamaica EBITDA. Adjusted EBITDA for the second quarter of 2025 increased sequentially from the last quarter primarily due to the addition of Jamaica EBITDA, partially offset by lower Atlantic Basin margin in the second quarter of 2025 and the timing of vessel operating costs. Net income for the second quarter of 2025 decreased from the prior year second quarter primarily due to transition and transaction costs incurred as a result of the Jamaica acquisition and an increase in interest expense, partially offset by the addition of Jamaica EBITDA. Adjusted net income and adjusted EBITDA for the second quarter of 2025 increased from the prior year second quarter primarily due to the addition of Jamaica EBITDA. KEY COMMERCIAL UPDATES In May 2025, Excelerate completed its acquisition of an integrated LNG and power platform in Jamaica, including the Montego Bay and Old Harbour LNG terminals, the Clarendon combined heat and power plant, and small-scale LNG storage and regasification sites across the island. The Company has begun optimizing these assets to drive near-term EBITDA growth through improved performance and expanded commercial activity. Excelerate is also deepening its presence in Jamaica and the broader Caribbean to enhance the overall return profile of the transaction. In July 2025, Excelerate finalized an agreement to purchase an LNG carrier. The vessel, which was renamed the Excelerate Shenandoah, will be used to service the previously announced mid-term Atlantic Basin supply deal. The LNG carrier also represents Excelerate's first owned asset to be selected as an FSRU conversion candidate. In July 2025, Excelerate signed a definitive agreement with Petrobras to install a reliquefaction unit on the floating regasification terminal Experience, located in Guanabara Bay, Brazil. The reliquefaction unit is expected to be installed during the next planned dry dock for the Experience. Once installed, this technology will help eliminate all excess cargo losses due to boil off and lower Excelerate's Scope 1 emissions, while upgrading the performance and life expectancy of the floating LNG terminal. LIQUIDITY AND CAPITAL RESOURCES As of June 30, 2025, Excelerate had $426.0 million in unrestricted cash and cash equivalents and the Company had no letters of credit under its revolving credit facility. All of the $500 million of undrawn capacity under the revolving credit facility was available for additional borrowings as of June 30, 2025. QUARTERLY CASH DIVIDEND UPDATE On July 31, 2025, Excelerate's Board of Directors approved a quarterly cash dividend equal to $0.08 per share, or $0.32 per share on an annualized basis, of Class A common stock, representing approximately a 33 percent increase from the prior quarter. The dividend is payable on September 4, 2025, to Class A common stockholders of record as of the close of business on August 20, 2025. With even greater confidence in its forward cash flow outlook following the Jamaica acquisition, Excelerate is now targeting a low double-digit annual dividend growth rate commencing in 2026 and continuing through 2028. REVISED 2025 FINANCIAL OUTLOOK Excelerate has revised its full year 2025 guidance range. On July 29th, the Company announced that it had raised its full year 2025 Adjusted EBITDA guidance to include the anticipated contribution from the Jamaica acquisition from May 14, 2025 through December 31, 2025. As announced, the Company expects Adjusted EBITDA to range between $420 million and $440 million for the full year 2025. Maintenance capex for 2025 is now expected to range between $65 million and $75 million. Committed Growth Capital for 2025 is now expected to range between $95 million and $105 million. The increase to Committed Growth Capital is primarily driven by the purchase of the LNG carrier, the Excelerate Shenandoah, in the third quarter. Actual results may differ materially from the Company's outlook as a result of, among other things, the factors described under 'Forward-Looking Statements' below. INVESTOR CONFERENCE CALL AND WEBCAST The Excelerate management team will host a conference call for investors and analysts at 8:30 a.m. Eastern Time (7:30 a.m. Central Time) on Monday, August 11, 2025. Investors are invited to access a live webcast of the conference call via the Investor Relations page on the Company's website at An archived replay of the call and a copy of the presentation will be on the website following the call. ABOUT EXCELERATE ENERGY Excelerate Energy, Inc. is a U.S.-based LNG company located in The Woodlands, Texas. Excelerate is changing the way the world accesses cleaner forms of energy by providing integrated services along the LNG-to-power value chain with an objective of delivering rapid-to-market and reliable LNG solutions to customers. The Company offers a full range of flexible regasification services from floating LNG terminals to infrastructure development to LNG supply and power generation. Excelerate has a presence in Abu Dhabi, Antwerp, Boston, Buenos Aires, Chattogram, Dhaka, Doha, Dubai, Hanoi, Helsinki, Jamaica, London, Rio de Janeiro, Singapore, and Washington, DC. For more information, please visit USE OF NON-GAAP FINANCIAL MEASURES The Company reports financial results in accordance with accounting principles generally accepted in the United States ('GAAP'). Included in this press release are certain financial measures that are not calculated in accordance with GAAP. They are designed to supplement, and not substitute, Excelerate's financial information presented in accordance with GAAP. The non-GAAP measures as defined by Excelerate may not be comparable to similar non-GAAP measures presented by other companies, and you are cautioned not to place undue reliance on this information. The presentation of such measures, which may include adjustments to exclude non-recurring items, should not be construed as an inference that Excelerate's future results, cash flows or leverage will be unaffected by other non-recurring items. Management believes that the following non-GAAP financial measures provide investors with additional useful information in evaluating the Company's performance and valuation. See the reconciliation of non-GAAP financial measures to the most comparable GAAP financial measure, including those measures presented as part of the Company's 2025 Financial Outlook, in the section titled 'Non-GAAP Reconciliation' below. Adjusted Gross Margin The Company uses Adjusted Gross Margin, a non-GAAP financial measure, which it defines as revenues less cost of LNG, gas and power and operating expenses, excluding depreciation and amortization, to measure its operational financial performance. Management believes Adjusted Gross Margin is useful because it provides insight into profitability and true operating performance excluding the implications of the historical cost basis of the Company's assets. Adjusted Net Income The Company uses Adjusted Net Income, a non-GAAP financial measure, which it defines as net income plus tax-effected transition and transaction expenses. Management believes Adjusted Net Income is useful because it provides insight into profitability excluding the impact of non-recurring charges related to the Jamaica acquisition. Adjusted EBITDA Adjusted EBITDA is a non-GAAP financial measure included as a supplemental disclosure because management believes it is a useful indicator of the Company's operating performance. The Company defines Adjusted EBITDA as net income before interest expense, income taxes, depreciation and amortization, accretion, non-cash long-term incentive compensation expense and items such as charges and non-recurring expenses that management does not consider as part of assessing ongoing operating performance. The Company adjusts net income for the items listed above to arrive at Adjusted EBITDA because these amounts can vary substantially from company to company within its industry depending upon accounting methods and book values of assets, capital structures and the method by which the assets were acquired. Adjusted EBITDA should not be considered as an alternative to, or more meaningful than, net income as determined in accordance with GAAP or as an indicator of the Company's operating performance or liquidity. This measure has limitations as certain excluded items are significant components in understanding and assessing a company's financial performance, such as a company's cost of capital and tax structure, as well as the historic costs of depreciable assets, none of which are components of Adjusted EBITDA. The Company's presentation of Adjusted EBITDA should not be construed as an inference that its results will be unaffected by unusual or non-recurring items. For the foregoing reasons, Adjusted EBITDA has significant limitations that affect its use as an indicator of the Company's profitability and valuation. Adjusted Earnings Per Share The Company uses Adjusted Earnings Per Share ('EPS'), a non-GAAP financial measure, which it defines as diluted EPS plus the per share impact of its tax-effected transition and transaction expenses. Management believes Adjusted EPSis useful because it provides insight on per share profitability excluding the impact of non-recurring charges related to the Jamaica acquisition. FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, about Excelerate and our industry that involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding: the ongoing integration of the Jamaica acquisition; our future results of operations or financial condition, business strategy and plans, expansion plans and strategy, both generally and specifically in the Caribbean region; economic conditions, both generally and in particular in the regions in which we operate or plan to operate; the use of the new LNG carrier Excelerate Shenandoah; plans for the reliquefaction unit on the floating regasification terminal Experience; and projections regarding annual dividend rate growth, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as 'anticipate,' 'believe,' 'consider,' 'contemplate,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will' or 'would' or the negative of these words or other similar terms or expressions. You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this press release primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described under 'Risk Factors' in Excelerate's Annual Report on Form 10‐K for the year ended December 31, 2024, our other filings with the Securities and Exchange Commission (the 'SEC'), and those identified in this press release, including, but not limited to, the following: our ability to successfully complete and realize the anticipated benefits of the Jamaica acquisition, our ability to manage integration risks of the Jamaica acquisition; unplanned issues, including time delays, unforeseen expenses, cost inflation, materials or labor shortages, which could result in delayed receipt of payment or existing or anticipated project cancellation; the competitive market for liquefied natural gas ('LNG') regasification services; changes in the supply of and demand for and price of LNG and natural gas and LNG regasification capacity; our need for substantial expenditures to maintain and replace, over the long-term, the operating capacity of our assets; risks associated with conducting business outside of the United States, including political, legal and economic risk; our ability to obtain and maintain approvals and permits from governmental and regulatory agencies with respect to the design, construction and operation of our facilities and provision of our services; our ability to access financing on favorable terms; our debt level and finance lease liabilities, which may limit our flexibility in obtaining additional financing, or refinancing credit facilities upon maturity; our financing agreements, which include financial restrictions and covenants and are secured by certain of our floating regasification terminals; our ability to enter into or extend contracts with customers and our customers' failure to perform their contractual obligations; our ability to purchase or receive physical delivery of LNG in sufficient quantities to satisfy our delivery and sales obligations or at attractive prices; our ability to maintain relationships with our existing suppliers, source new suppliers for LNG and critical components of our projects and complete building out our supply chain; the technical complexity of our infrastructure assets; the risks inherent in operating our infrastructure assets; customer termination rights in our contracts; adverse effects on our operations due to disruption of third-party facilities; infrastructure constraints and community and political group resistance to existing and new LNG and natural gas infrastructure over concerns about the environment, safety and terrorism; shortages of qualified officers and crew impairing our ability to operate or increasing the cost of crewing our floating regasification terminals; acts of terrorism, war or political or civil unrest; compliance with various international treaties and conventions and national and local environmental, health, safety and maritime conduct laws that affect our operations; and other risks, uncertainties and factors set forth in any of our filings with the SEC. These risks and uncertainties are described more fully in our other filings with the SEC, including our most recent Annual Report on Form 10-K. All forward-looking statements are based on assumptions or judgments about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Excelerate. The occurrence of any such factors, events or circumstances would significantly alter the results set forth in these statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Form 10-Q. For example, the current global economic uncertainty and geopolitical climate, including wars and conflicts, and world or regional health events, including pandemics and epidemics and governmental and third-party responses thereto, may give rise to risks that are currently unknown or amplify the risks associated with many of the foregoing events or factors. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements. In addition, statements that 'we believe' and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Form 10-Q. While we believe that the statements provided herein are supported by information obtained in a reasonable manner, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements. The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments. View source version on CONTACT: Investors Craig Hicks Excelerate Energy [email protected] Stephen Pettibone / Frances Jeter FGS Global [email protected] or [email protected] KEYWORD: UNITED STATES NORTH AMERICA TEXAS INDUSTRY KEYWORD: OTHER ENERGY MARITIME LOGISTICS/SUPPLY CHAIN MANAGEMENT OIL/GAS TRANSPORT ENERGY OTHER TRANSPORT SOURCE: Excelerate Energy, Inc. Copyright Business Wire 2025. PUB: 08/11/2025 06:30 AM/DISC: 08/11/2025 06:29 AM
Associated Press
a minute ago
- Associated Press
Owens & Minor Reports Second Quarter 2025 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)--Aug 11, 2025-- Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company's continuing operations which primarily represent what was previously the Patient Direct segment and certain functional operations. 'We are in the final stages of our robust process for the divestiture of the Products & Healthcare Services segment, and, as a result, have classified this segment as discontinued operations. We are looking forward to concluding the sale of the business and working with a buyer who has the vision and greater flexibility to better support our customers and long-term growth,' said Ed Pesicka, Owens & Minor's Chief Executive Officer. Mr. Pesicka concluded, 'I am excited about the opportunities ahead as we transition into a focused, pure-play Patient Direct business. Building on the momentum gained since we entered the Patient Direct space eight years ago, and supported by favorable demographic trends and meaningful scale, we are confident in our ability to lead as the market continues to evolve.' 2025 Continuing Operations Financial Outlook The Company will provide its 2025 financial outlook for continuing operations during its earnings conference call this morning at 8:30 a.m. EDT. Investor Conference Call for Second Quarter 2025 Financial Results Owens & Minor will host a conference call for investors and analysts on Monday, August 11, 2025, at 8:30 a.m. EDT. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at A replay of the webcast can be accessed following the presentation at the link provided above. Safe Harbor This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain 'forward looking' statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the statements in this release regarding our future prospects and performance, including our expectations with respect to our financial performance, our 2025 financial results, Owens & Minor's ability to successfully complete the sale of the P&HS business in any specific transaction on favorable terms or at all, our cost saving initiatives, future indebtedness and growth, industry trends, as well as statements related to our expectations regarding the performance of our business, including our ability to address macro and market conditions. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Investors should refer to Owens & Minor's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 28, 2025, including the section captioned 'Item 1A. Risk Factors,' as applicable, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause the Company's actual results to differ materially from its current estimates. These filings are available at Given these risks and uncertainties, Owens & Minor can give no assurance that any forward-looking statements will, in fact, transpire and, therefore, cautions investors not to place undue reliance on them. Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. About Owens & Minor Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™. For more information about Owens & Minor and our affiliated brands, visit or follow us on LinkedIn and Instagram. * Registered Trademark or Trademark of O&M Halyard or its affiliates. Share-based awards for the three months ended June 30, 2025 and 2024 of approximately 2.5 million and 1.6 million shares were excluded from the calculation of diluted loss per common share as the effect would be anti-dilutive. Share-based awards for the six months ended June 30, 2025 and 2024 of approximately 2.2 million and 1.6 million shares were excluded from the calculation of diluted loss per common share as the effect would be anti-dilutive. The following table provides a reconciliation of reported operating (loss) income, net loss from continuing operations, net of tax and net loss from continuing operations per share to non-GAAP measures used by management. The following tables provide reconciliations of net loss from continuing operations, net of tax and total debt to non-GAAP measures used by management. The following tables provide reconciliations of capital expenditures to a non-GAAP measure used by management. Use of Non-GAAP Measures This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.'s (the Company) core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate the Company's performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation. Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on its financial and operating results and in comparing the Company's performance to that of its competitors. However, the non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The non-GAAP financial measures disclosed by the Company should not be considered substitutes for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated. OMI-CORP OMI-IR SOURCE: Owens & Minor, Inc. View source version on CONTACT: Investors Alpha IR Group Jackie Marcus or Nick Teves [email protected] Leon Executive Vice President & Chief Financial Officer [email protected] Stacy Law [email protected] KEYWORD: UNITED STATES NORTH AMERICA VIRGINIA INDUSTRY KEYWORD: MEDICAL SUPPLIES MEDICAL DEVICES HEALTH HOSPITALS SURGERY MANAGED CARE SOURCE: Owens & Minor, Inc. Copyright Business Wire 2025. PUB: 08/11/2025 06:30 AM/DISC: 08/11/2025 06:29 AM
